Cited by 485Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 61 of the 62 references it cites were found in a registry or an index.

The presenilin hypothesis of Alzheimer’s disease: Evidence for a loss-of-function pathogenic mechanism.

Open access

Shen, Jie, Kelleher, Raymond J.·2007·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.0608332104PMC PMC1766397

Open this paper in CoChat — free account

Abstract

Dominantly inherited mutations in the genes encoding presenilins (PS) and the amyloid precursor protein (APP) are the major causes of familial Alzheimer's disease (AD). The prevailing view of AD pathogenesis posits that accumulation of β-amyloid (Aβ) peptides, particularly Aβ42, is the central event triggering neurodegeneration. Emerging evidence, however, suggests that loss of essential functions of PS could better explain dementia and neurodegeneration in AD. First, conditional inactivation of PS in the adult mouse brain causes progressive memory loss and neurodegeneration resembling AD, whereas mouse models based on overproduction of Aβ have failed to produce neurodegeneration. Second, whereas pathogenic PS mutations enhance Aβ42 production, they typically reduce Aβ40 generation and impair other PS-dependent activities. Third, γ-secretase inhibitors can enhance the production of Aβ42 while blocking other γ-secretase activities, thus mimicking the effects of PS mutations. Finally, PS mutations have been identified in frontotemporal dementia, which lacks amyloid pathology. Based on these and other observations, we propose that partial loss of PS function may underlie memory impairment and neurodegeneration in the pathogenesis of AD. We also speculate that Aβ42 may act primarily to antagonize PS-dependent functions, possibly by operating as an active site-directed inhibitor of γ-secretase.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1073/pnas.0608332104

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Regulation of NMDA receptor trafficking by amyloid-β
Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., Nairn, A. C., Salter, M. W., Lombroso, P. J., Gouras, G. K., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1503 · Cited by 1,561
A Transcriptively Active Complex of APP with Fe65 and Histone Acetyltransferase Tip60
Cao, X., & Südhof, T. C. (2001) · Science · doi:10.1126/science.1058783 · Cited by 1,202
Skeletal and CNS Defects in Presenilin-1-Deficient Mice
Shen, J., Bronson, R. T., Chen, D. F., Xia, W., Selkoe, D. J., & Tonegawa, S. (1997) · Cell · doi:10.1016/s0092-8674(00)80244-5 · Cited by 959
Self-citation
Loss of Presenilin Function Causes Impairments of Memory and Synaptic Plasticity Followed by Age-Dependent Neurodegeneration
Saura, C. A., Choi, S.-Y., Beglopoulos, V., Malkani, S., Zhang, D., Rao, B. S. S., Chattarji, S., Kelleher, R. J., Kandel, E. R., Duff, K., et al. (2004) · Neuron · doi:10.1016/s0896-6273(04)00182-5 · Cited by 757
Self-citation
A presenilin‐1/γ‐secretase cleavage releases the E‐cadherin intracellular domain and regulates disassembly of adherens junctions
Marambaud, P., Shioi, J., Serban, G., Georgakopoulos, A., Sarner, S., Nagy, V., Baki, L., Wen, P., Efthimiopoulos, S., Shao, Z., et al. (2002) · The EMBO Journal · doi:10.1093/emboj/21.8.1948 · Cited by 686
APPSW Transgenic Mice Develop Age-related Aβ Deposits and Neuropil Abnormalities, but no Neuronal Loss in CA1
IRIZARRY, M. C., MCNAMARA, M., FEDORCHAK, K., HSIAO, K., & HYMAN, B. T. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199709000-00002 · Cited by 649
Presenilins Form ER Ca2+ Leak Channels, a Function Disrupted by Familial Alzheimer's Disease-Linked Mutations
Tu, H., Nelson, O., Bezprozvanny, A., Wang, Z., Lee, S.-F., Hao, Y.-H., Serneels, L., De Strooper, B., Yu, G., & Bezprozvanny, I. (2006) · Cell · doi:10.1016/j.cell.2006.06.059 · Cited by 616

Show all 62 references

Sorted by citations

Items 101–200 of 484

Inhibition of γ-secretase worsens memory deficits in a genetically congruous mouse model of Danish dementia
Tamayev, R., & D’Adamio, L. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-19 · Cited by 81
Presenilin/γ-Secretase Regulates Neurexin Processing at Synapses
Saura, C. A., Servián‐Morilla, E., & Scholl, F. G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019430 · Cited by 80
Do anti-amyloid beta protein antibody cross reactivities confound Alzheimer disease research?
Hunter, S., & Brayne, C. (2017) · Journal of Negative Results in BioMedicine · doi:10.1186/s12952-017-0066-3 · Cited by 80
Presenilin transgenic mice as models of Alzheimer’s disease
Elder, G. A., Sosa, M. A. G., Gasperi, R. D., Dickstein, D. L., & Hof, P. R. (2009) · Brain Structure and Function · doi:10.1007/s00429-009-0227-3 · Cited by 76
Comparison of Aβ levels in the brain of familial and sporadic Alzheimer's disease
Hellström‐Lindahl, E., Viitanen, M. H., & Marutle, A. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2009.03.007 · Cited by 78
Aspects of β-Amyloid as a Biomarker for Alzheimer's Disease
Andréasson, U., Portelius, E., Andersson, M. E., Blennow, K., & Zetterberg, H. (2007) · Biomarkers in Medicine · doi:10.2217/17520363.1.1.59 · Cited by 74
Insulin resistance, neuroinflammation, and Alzheimer’s disease
Najem, D., Bamji‐Mirza, M., Chang, N., Liu, Q. Y., & Zhang, W. (2014) · Reviews in the Neurosciences · doi:10.1515/revneuro-2013-0050 · Cited by 76
Phenylbutyric Acid Rescues Endoplasmic Reticulum Stress-Induced Suppression of APP Proteolysis and Prevents Apoptosis in Neuronal Cells
Wiley, J. C., Meabon, J. S., Frankowski, H., Smith, E. A., Schecterson, L. C., Bothwell, M. A., & Ladiges, W. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009135 · Cited by 73
Endogenous Aβ causes cell death via early tau hyperphosphorylation
Amadoro, G., Corsetti, V., Ciotti, M. T., Florenzano, F., Capsoni, S., Amato, G., & Calissano, P. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.06.005 · Cited by 74
Brain Gene Expression of a Sporadic (icv-STZ Mouse) and a Familial Mouse Model (3xTg-AD Mouse) of Alzheimer’s Disease
Chen, Y., Tian, Z., Liang, Z., Sun, S., Dai, C., Lee, M. H., LaFerla, F. M., Grundke, I., Iqbal, K., Liu, F., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051432 · Cited by 74
Lost in translation: Inconvenient truths on the utility of mouse models in Alzheimer’s disease research
Granzotto, A., Vissel, B., & Sensi, S. L. (2024) · eLife · doi:10.7554/elife.90633 · Cited by 71
Generation and deposition of Aβ43 by the virtually inactive presenilin‐1 L435F mutant contradicts the presenilin loss‐of‐function hypothesis of Alzheimer's disease
Kretner, B., Trambauer, J., Fukumori, A., Mielke, J., Kuhn, P., Kremmer, E., Giese, A., Lichtenthaler, S. F., Haass, C., Arzberger, T., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201505952 · Cited by 68
Alzheimer's disease-causing presenilin-1 mutations have deleterious effects on mitochondrial function
Han, J., Park, H.-J., Maharana, C., Gwon, A., Park, J., Baek, S. H., Bae, H., Cho, Y., Kim, H. K., Sul, J. H., et al. (2021) · Theranostics · doi:10.7150/thno.59776 · Cited by 68
Dissecting Complex and Multifactorial Nature of Alzheimer’s Disease Pathogenesis: a Clinical, Genomic, and Systems Biology Perspective
Talwar, P., Sinha, J., Grover, S., Rawat, C., Kushwaha, S. S., Agarwal, R., Taneja, V., & Kukreti, R. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9390-0 · Cited by 71
Dementia: Alzheimer pathology and vascular factors: From mutually exclusive to interaction
van Norden, A. G. W., van Dijk, E. J., de Laat, K. F., Scheltens, P., Olde-Rikkert, M. G. M., & de Leeuw, F. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.07.003 · Cited by 75
Neurodegeneration in Alzheimer Disease: Role of Amyloid Precursor Protein and Presenilin 1 Intracellular Signaling
Nizzari, M., Thellung, S., Corsaro, A., Villa, V., Pagano, A., Porcile, C., Russo, C., & Florio, T. (2012) · Journal of Toxicology · doi:10.1155/2012/187297 · Cited by 71
Protease Regulation: The Yin and Yang of Neural Development and Disease
Bai, G., & Pfaff, S. L. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.012 · Cited by 70
Apolipoprotein E-Mimetics Inhibit Neurodegeneration and Restore Cognitive Functions in a Transgenic Drosophila Model of Alzheimer's Disease
Sarantseva, S. V., Timoshenko, S., Bolshakova, O. I., Karaseva, E., Rodin, D., Schwarzman, A. L., & Vitek, M. P. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008191 · Cited by 70
Trans-Dominant Negative Effects of Pathogenic PSEN1 Mutations on -Secretase Activity and A Production
Heilig, E. A., Gutti, U., Tai, T., Shen, J., & Kelleher, R. J. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0954-13.2013 · Cited by 70
Self-citation
Prion and Prion-Like Protein Strains: Deciphering the Molecular Basis of Heterogeneity in Neurodegeneration
Scialò, C., Cecco, E. D., Manganotti, P., & Legname, G. (2019) · Viruses · doi:10.3390/v11030261 · Cited by 69
Exploring the Role of PSEN Mutations in the Pathogenesis of Alzheimer’s Disease
Kabir, M. T., Uddin, M. S., Setu, J. R., Ashraf, G. M., Bin-Jumah, M. N., & Abdel‐Daim, M. M. (2020) · Neurotoxicity Research · doi:10.1007/s12640-020-00232-x · Cited by 72
Modulation of γ- and β-secretases as early prevention against Alzheimer's disease
Voytyuk, I., De Strooper, B., & Chávez-Gutiérrez, L. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.08.001 · Cited by 67
Animal models of dementia
Roberson, E. D., & Kao, A. W. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511581410.010 · Cited by 67
Presenilin controls kinesin-1 and dynein function during APP-vesicle transport in vivo
Gunawardena, S., Yang, G., & Goldstein, L. S. B. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt237 · Cited by 66
The functional neurophysiology of the amyloid precursor protein (APP) processing pathway
Randall, A. D., Witton, J., Booth, C., Hynes-Allen, A. M., & Brown, J. T. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.02.011 · Cited by 66
γ-Secretase inhibitor reduces diet-induced atherosclerosis in apolipoprotein E-deficient mice
Aoyama, T., Takeshita, K., Kikuchi, R., Yamamoto, K., Cheng, X. W., Liao, J. K., & Murohara, T. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.03.154 · Cited by 65
The benefits of exercise on structural and functional plasticity in the rodent hippocampus of different disease models.
Patten, A. R., Yau, S. Y., Fontaine, C. J., Meconi, A., Wortman, R. C., & Christie, B. R. (2015) · Brain Plasticity · doi:10.3233/bpl-150016 · Cited by 64
Tau Aggregation in Alzheimer's Disease: What Role for Phosphorylation?
Lippens, G., Sillen, A., Landrieu, I., Amniai, L., Sibille, N., Barbier, P., Leroy, A., Hanoulle, X., & Wieruszeski, J.-M. (2007) · Prion · doi:10.4161/pri.1.1.4055 · Cited by 68
Histopathological and molecular heterogeneity among individuals with dementia associated with Presenilin mutations
Maarouf, C. L., Daugs, I. D., Spina, S., Vidal, R., Kokjohn, T. A., Patton, R., Kalback, W. M., Luehrs, D. C., Walker, D. G., Castaño, E. M., et al. (2008) · Molecular Neurodegeneration · doi:10.1186/1750-1326-3-20 · Cited by 65
Targets for AD treatment: conflicting messages from γ-secretase inhibitors
Sambamurti, K., Greig, N. H., Utsuki, T., Barnwell, E., Sharma, E., Mazell, C., Bhat, N. R., Kindy, M. S., Lahiri, D. K., & Pappolla, M. A. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07213.x · Cited by 62
MicroRNAs and Alzheimer′s Disease Mouse Models: Current Insights and Future Research Avenues
Delay, C., & Hébert, S. S. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/894938 · Cited by 63
Modeling Alzheimer’s disease: from past to future
Saraceno, C., Musardo, S., Marcello, E. E., Pelucchi, S., & Luca, M. D. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00077 · Cited by 62
Danish dementia mice suggest that loss of function and not the amyloid cascade causes synaptic plasticity and memory deficits
Tamayev, R., Matsuda, S., Fà, M., Arancio, O., & D'adamio, L. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011689107 · Cited by 61
Is γ-secretase a beneficial inactivating enzyme of the toxic APP C-terminal fragment C99?
Checler, F., Afram, E., Pardossi‐Piquard, R., & Lauritzen, I. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100489 · Cited by 63
Presenilin 2 influences miR146 level and activity in microglia
Jayadev, S., Case, A., Alajajian, B., Eastman, A. J., Möller, T., & Garden, G. A. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12400 · Cited by 62
Pen2 and Presenilin-1 Modulate the Dynamic Equilibrium of Presenilin-1 and Presenilin-2 γ-Secretase Complexes
Placanica, L., Tarassishin, L., Yang, G., Peethumnongsin, E., Kim, S., Zheng, H., Sisodia, S. S., & Li, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m807269200 · Cited by 60
Presenilin 2 Is the Predominant γ-Secretase in Microglia and Modulates Cytokine Release
Jayadev, S., Case, A., Eastman, A. J., Nguyen, H., Pollak, J., Wiley, J. C., Möller, T., Morrison, R. S., & Garden, G. A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015743 · Cited by 60
Targeting the NMDA receptor subunit NR2B for treating or preventing age-related memory decline
Wang, D., Jacobs, S., & Tsien, J. Z. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.941286 · Cited by 59
Therapeutic Strategies to Target Calcium Dysregulation in Alzheimer’s Disease
Calvo-Rodríguez, M., Kharitonova, E. K., & Bacskai, B. J. (2020) · Cells · doi:10.3390/cells9112513 · Cited by 60
Mechanisms of neurodegeneration — Insights from familial Alzheimer’s disease
Chávez‐Gutiérrez, L., & Szaruga, M. (2020) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.03.005 · Cited by 59
Alzheimer's disease in a dish: promises and challenges of human stem cell models
Young, J. E., & Goldstein, L. S. B. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds319 · Cited by 57
BRI3 Inhibits Amyloid Precursor Protein Processing in a Mechanistically Distinct Manner from Its Homologue Dementia Gene BRI2
Matsuda, S., Matsuda, Y., & D'adamio, L. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.006403 · Cited by 57
Protein mishandling and impaired lysosomal proteolysis generated through calcium dysregulation in Alzheimer’s disease
Mustaly-Kalimi, S., Gallegos, W., Marr, R. A., Gilman-Sachs, A., Peterson, D. A., Sekler, I., & Stutzmann, G. E. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2211999119 · Cited by 55
Evidence For and Against a Pathogenic Role of Reduced γ-Secretase Activity in Familial Alzheimer’s Disease
Jayne, T., Newman, M., Verdile, G., Sutherland, G. T., Münch, G. W., Musgrave, I., Nik, S. H. M., & Lardelli, M. T. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151186 · Cited by 54
Effect of Presenilin Mutations on APP Cleavage; Insights into the Pathogenesis of FAD
Li, N., Liu, K., Qiu, Y., Ren, Z., Dai, R., Deng, Y., & Qing, H. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00051 · Cited by 62
Presenilin-1 mutation impairs cholinergic modulation of synaptic plasticity and suppresses NMDA currents in hippocampus slices
Wang, Y., Greig, N. H., Yu, Q.-S., & Mattson, M. P. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.10.009 · Cited by 53
Targeting increased levels of APP in Down syndrome: Posiphen‐mediated reductions in APP and its products reverse endosomal phenotypes in the Ts65Dn mouse model
Chen, X., Salehi, A., Pearn, M. L., Overk, C., Nguyen, P. D., Kleschevnikov, A. M., Maccecchini, M. L., & Mobley, W. C. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12185 · Cited by 55
Physiological and pathological roles of the γ-secretase complex
Carroll, C. M., & Li, Y. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.04.019 · Cited by 58
The Anti-Amyloid Monoclonal Antibody Lecanemab: 16 Cautionary Notes
Kepp, K. P., Sensi, S. L., Johnsen, K. B., Barrio, J. R., Høilund‐Carlsen, P. F., Neve, R. L., Alavi, A. A., Herrup, K., Perry, G. L., Robakis, N. K. R. K., et al. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230099 · Cited by 56
C-terminal fragment of N-cadherin accelerates synapse destabilization by amyloid-β
Andreyeva, A., Nieweg, K., Horstmann, K., Klapper, S. D., Müller‐Schiffmann, A., Korth, C., & Gottmann, K. (2012) · Brain · doi:10.1093/brain/aws120 · Cited by 52
ubiquilin antagonizes presenilin and promotes neurodegeneration in Drosophila
Ganguly, A., Feldman, R. M. R., & Guo, M. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm305 · Cited by 49
Targeted proteomics in Alzheimer’s disease: focus on amyloid-β
Portelius, E., Zetterberg, H., Gobom, J., Andréasson, U., & Blennow, K. (2008) · Expert Review of Proteomics · doi:10.1586/14789450.5.2.225 · Cited by 52
Loss of stability and hydrophobicity of presenilin 1 mutations causing Alzheimer's disease
Somavarapu, A. K., & Kepp, K. P. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13535 · Cited by 49
Presenilins in synaptic function and disease.
Ho, A., & Shen, J. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.06.002 · Cited by 52
Self-citation
Inactivation of presenilins causes pre‐synaptic impairment prior to post‐synaptic dysfunction
Zhang, D., Zhang, C., Ho, A., Kirkwood, A., Südhof, T. C., & Shen, J. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07011.x · Cited by 50
Self-citation
Unraveling the complexity of γ-secretase
Wolfe, M. S. (2020) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.01.005 · Cited by 51
Non-productive angiogenesis disassembles Aß plaque-associated blood vessels
Álvarez-Vergara, M. I., Rosales‐Nieves, A. E., March‐Díaz, R., Rodríguez-Periñán, G., Lara-Ureña, N., Luis, C. O. S., Sánchez-García, M. A., Martín‐Bórnez, M., Gómez‐Gálvez, P., Vicente‐Munuera, P., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23337-z · Cited by 49
Searching for new animal models of Alzheimer′s disease
Epis, R., Gardoni, F., Marcello, E. E., Genazzani, A. A., Canonico, P. L., & Luca, M. D. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.10.020 · Cited by 51
Synaptic contact number and size in stratum radiatum CA1 of APP/PS1ΔE9 transgenic mice
West, M. J., Bach, G., Søderman, A., & Jensen, J. L. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.01.009 · Cited by 48
Dual Role of α-Secretase Cleavage in the Regulation of γ-Secretase Activity for Amyloid Production
Tian, Y., Crump, C. J., & Li, Y.-M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.128439 · Cited by 42
γ-Secretase and Human Disease
Kelleher, R. J., & Shen, J. (2010) · Science · doi:10.1126/science.1198668 · Cited by 47
Self-citation
Partial Loss of Presenilin Impairs Age-Dependent Neuronal Survival in the Cerebral Cortex
Watanabe, H., Iqbal, M., Zheng, J., Wines-Samuelson, M., & Shen, J. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.3261-14.2014 · Cited by 48
Self-citation
Loss of presenilin function causes Alzheimer's disease‐like neurodegeneration in the mouse
Chen, Q., Nakajima, A., Choi, S. H., Xiong, X., & Tang, Y. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21601 · Cited by 47
Processing of Mutant β-Amyloid Precursor Protein and the Clinicopathological Features of Familial Alzheimer’s Disease
Bi, C., Bi, S., & Li, B. (2018) · Aging and Disease · doi:10.14336/ad.2018.0425 · Cited by 46
Substrate recognition and processing by γ-secretase
Wolfe, M. S. (2019) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2019.07.004 · Cited by 49
Mesoporous silica nanoparticles: Their potential as drug delivery carriers and nanoscavengers in Alzheimer's and Parkinson's diseases
Attia, M. S., Yahya, A. S., Abdelmonaem, N., & Sabry, S. A. (2023) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2023.01.009 · Cited by 45
Toward the structure of presenilin/γ-secretase and presenilin homologs
Wolfe, M. S. (2013) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2013.04.015 · Cited by 47
Pharmacological and Genetic Reversal of Age-Dependent Cognitive Deficits Attributable to Decreased presenilin Function
McBride, S. M. J., Choi, C. H., Schoenfeld, B. P., Bell, A. J., Liebelt, D. A., Ferreiro, D., Choi, R. J., Hinchey, P., Kollaros, M., Terlizzi, A. M., et al. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1017-10.2010 · Cited by 42
Presenilin mouse and zebrafish models for dementia: Focus on neurogenesis
van Tijn, P., Kamphuis, W., Marlatt, M. W., Hol, E. M., & Lucassen, P. J. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.10.008 · Cited by 43
Cellular mechanisms of γ-secretase substrate selection, processing and toxicity
Barthet, G., Georgakopoulos, A., & Robakis, N. K. R. K. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.05.006 · Cited by 43
The Senescence Hypothesis of Disease Progression in Alzheimer Disease: an Integrated Matrix of Disease Pathways for FAD and SAD
Hunter, S., Arendt, T., & Brayne, C. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8445-3 · Cited by 41
Loss of presenilin function is associated with a selective gain of APP function
Deyts, C., Clutter, M., Herrera, S., Jovanovic, N., GODDI, A. A., & Parent, A. (2016) · eLife · doi:10.7554/elife.15645 · Cited by 41
The silence of the fats: A MAM’s story about Alzheimer
Agrawal, R. R., Montesinos, J., Larrea, D., Área-Gómez, E., & Pera, M. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105062 · Cited by 42
Die Alzheimer‐Demenz: von der Pathologie zu therapeutischen Ansätzen
Jakob‐Roetne, R., & Jacobsen, H. (2009) · Angewandte Chemie · doi:10.1002/ange.200802808 · Cited by 41
A neurodegenerative disease landscape of rare mutations in Colombia due to founder effects
Acosta‐Uribe, J., Aguillon, D. F., Cochran, J. N., Giraldo, M., Madrigal, L., Killingsworth, B. W., Singhal, R., Labib, S., Alzate, D., Velilla, L. M., et al. (2022) · Genome Medicine · doi:10.1186/s13073-022-01035-9 · Cited by 43
Presenilin mediates neuroprotective functions of ephrinB and brain-derived neurotrophic factor and regulates ligand-induced internalization and metabolism of EphB2 and TrkB receptors
Barthet, G., Dunys, J., Shao, Z., Zhao, X., Ren, Y., Xu, J., Arbez, N., Mauger, G., Bruban, J., Georgakopoulos, A., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.02.024 · Cited by 40
Amyloid‐beta reduction by memapsin 2 (beta‐secretase) immunization
Chang, W., Downs, D., Huang, X., Da, H., Fung, K.-M. A., & Tang, J. (2007) · The FASEB Journal · doi:10.1096/fj.06-7993com · Cited by 40
Nicastrin Is Dispensable for γ-Secretase Protease Activity in the Presence of Specific Presenilin Mutations
Futai, E., Yagishita, S., & Ishiura, S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807653200 · Cited by 39
Neuronal activity and secreted amyloid β lead to altered amyloid β precursor protein and presenilin 1 interactions
Li, X., Uemura, K., Hashimoto, T., Nasser-Ghodsi, N., Arimon, M., Lill, C. M., Palazzolo, I., Krainc, D., Hyman, B. T., & Berezovska, O. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.10.002 · Cited by 38
Ube3a deficiency inhibits amyloid plaque formation in APPswe/PS1δE9 mouse model of Alzheimer’s disease
Singh, B. K., Vatsa, N., Kumar, V., Shekhar, S., Sharma, A., & Jana, N. R. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx295 · Cited by 38
Intramembrane Proteolysis of GXGD-type Aspartyl Proteases Is Slowed by a Familial Alzheimer Disease-like Mutation
Fluhrer, R., Fukumori, A., Martin, L., Grammer, G., Haug‐Kröper, M., Klier, B., Winkler, E., Kremmer, E., Condron, M. M., Teplow, D. B., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806092200 · Cited by 38
Impaired Neurotransmitter Release in Alzheimer’s and Parkinson’s Diseases
Shen, J. (2010) · Neurodegenerative Diseases · doi:10.1159/000285511 · Cited by 38
Self-citation
Integrin-mediated regulation of neurovascular development, physiology and disease
McCarty, J. H. (2009) · Cell Adhesion & Migration · doi:10.4161/cam.3.2.7767 · Cited by 37
New precision medicine avenues to the prevention of Alzheimer’s disease from insights into the structure and function of γ-secretases
De Strooper, B., & Karran, E. (2024) · The EMBO Journal · doi:10.1038/s44318-024-00057-w · Cited by 36
Familial Alzheimer mutations stabilize synaptotoxic γ-secretase-substrate complexes
Devkota, S., Zhou, R., Nagarajan, V., Maesako, M., Do, H. N., Noorani, A. A., Overmeyer, C., Bhattarai, S., Douglas, J. T., Saraf, A., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113761 · Cited by 36
An agnostic reevaluation of the amyloid cascade hypothesis of Alzheimer's disease pathogenesis: The role of APP homeostasis
Caselli, R. J., Knopman, D. S., & Bu, G. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12124 · Cited by 36
Presenilin-2 modulation of ER-mitochondria interactions
Zampese, E., Fasolato, C., Pozzan, T., & Pizzo, P. (2011) · Communicative & Integrative Biology · doi:10.4161/cib.4.3.15160 · Cited by 36
Increased oxidative stress and astrogliosis responses in conditional double-knockout mice of Alzheimer-like presenilin-1 and presenilin-2
Zhu, M., Gu, F., Shi, J., Hu, J., Hu, Y., & Zhao, Z. Y. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.08.027 · Cited by 35
Molecular Determinants and Thermodynamics of the Amyloid Precursor Protein Transmembrane Domain Implicated in Alzheimer's Disease
Wang, H., Barreyro, L., Provasi, D., Djemil, I., Torres-Arancivia, C., Filizola, M., & Ubarretxena‐Belandia, I. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.03.028 · Cited by 35
Alzheimer's disease‐causing proline substitutions lead to presenilin 1 aggregation and malfunction
Ben‐Gedalya, T., Moll, L., Bejerano‐Sagie, M., Frère, S. G. A., Cabral, W. A., Friedmann‐Morvinski, D., Slutsky, I., Burstyn‐Cohen, T., Marini, J. C., & Cohen, E. (2015) · The EMBO Journal · doi:10.15252/embj.201592042 · Cited by 35
Familial Alzheimer’s disease-associated PSEN1 mutations affect neurodevelopment through increased Notch signaling
Hurley, E. M., Mozolewski, P., Dobrowolski, R., & Hsieh, J. (2023) · Stem Cell Reports · doi:10.1016/j.stemcr.2023.05.018 · Cited by 38
Comparison of Presenilin 1 and Presenilin 2 γ-Secretase Activities Using a Yeast Reconstitution System
Yonemura, Y., Futai, E., Yagishita, S., Suo, S., Tomita, T., Iwatsubo, T., & Ishiura, S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.270108 · Cited by 35
Side-by-side comparison of Notch- and C83 binding to γ-secretase in a complete membrane model at physiological temperature
Dehury, B., Tang, N., Mehra, R., Blundell, T. L., & Kepp, K. P. (2020) · RSC Advances · doi:10.1039/d0ra04683c · Cited by 33
Multifaceted Alzheimer’s Disease: Building a Roadmap for Advancement of Novel Therapies
Kaur, D., Behl, T., Sehgal, A., Singh, S., Sharma, N., & BUNGAU, S. G. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03415-w · Cited by 34
Does Data-Independent Acquisition Data Contain Hidden Gems? A Case Study Related to Alzheimer’s Disease
Hubbard, E. E., Heil, L. R., Merrihew, G. E., Chhatwal, J. P., Farlow, M. R., McLean, C., Ghetti, B. F., Newell, K. L., Frosch, M. P., Bateman, R. J., et al. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00558 · Cited by 33
The Mitochondrial Secret(ase) of Alzheimer's Disease
Young, K. J., & Bennett, J. P. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100360 · Cited by 34
Generation and Initial Characterization of FDD Knock In Mice
Giliberto, L., Matsuda, S., Vidal, R., & D'adamio, L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007900 · Cited by 33
Excitatory synaptic transmission is depressed in cultured hippocampal neurons of APP/PS1 mice
Priller, C., Mitteregger, G., Paluch, S., Vassallo, N., Staufenbiel, M., Kretzschmar, H. A., Jucker, M., & Herms, J. W. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.10.016 · Cited by 33
Loss of Aβ43 Production Caused by Presenilin-1 Mutations in the Knockin Mouse Brain
Xia, D., Kelleher, R. J., & Shen, J. (2016) · Neuron · doi:10.1016/j.neuron.2016.03.009 · Cited by 34
Self-citation
Ca2+ dysregulation in the endoplasmic reticulum related to Alzheimer’s disease: A review on experimental progress and computational modeling
Liang, J., Kulasiri, D., & Samarasinghe, S. (2015) · Biosystems · doi:10.1016/j.biosystems.2015.05.003 · Cited by 33

Authors: Shen, J., & Kelleher, R. J.
Affiliations: Brigham and Women's Hospital (US)
Harvard University (US)
ORCID: Shen, Jie
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 2007-01-09
Volume: 104
Issue: 2
Pages: 403-409
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.0608332104
PMC: PMC1766397
OpenAlex: W2041601288
Cited by: 485
References: 62
Citations by year: 2026: 9 · 2025: 14 · 2024: 22 · 2023: 32 · 2022: 16 · 2021: 20 · 2020: 31 · 2019: 21 · 2018: 19 · 2017: 26 · 2016: 24 · 2015: 20 · 2014: 14 · 2013: 31 · 2012: 32
FWCI: 3.36
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Alzheimer's Association
National Institutes of Health
National Institute of Neurological Disorders and Stroke (RF1NS041783, R01NS041783)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: presenilin, Alzheimer's disease, familial Alzheimer's disease, loss-of-function mechanism, amyloid precursor protein, amyloid-beta, amyloid-beta 42, Aβ40, gamma-secretase, gamma-secretase inhibitors, conditional knockout mice, memory loss, neurodegeneration, frontotemporal dementia, presenilin mutations
MeSH terms: Alzheimer Disease, Amino Acid Sequence, Animals, Brain, Disease Models, Animal, Humans, Models, Neurological, Molecular Sequence Data, Mutation, Nerve Degeneration, Amyloid beta-Protein Precursor, Mice, Knockout, Mice, Presenilins, Amyloid Precursor Protein Secretases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The presenilin hypothesis of Alzheimer’s disease: Evidence for a loss-of-function pathogenic mechanism.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks